Numerous studies have demonstrated the overexpression of IL-15 mRNA and protein in CTCL and the level of IL-15 is predictive of the disease severity (32, 38–40). This evidence concerns the gene IL15 and primary cutaneous T-cell non-Hodgkin lymphoma.